Last reviewed · How we verify
NCT05453357
Feasibility and Acceptability of a Remote Glucose Monitoring Program for Pregnant Marshallese Women
trial testing iGlucose in Diabetes, Gestational. Withdrawn.
10 October 2024
Quick facts
| Lead sponsor | University of Arkansas |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 10 October 2024 |
| Primary completion | 10 October 2024 |
| Estimated completion | 10 October 2024 |
Drugs / interventions tested
- iGlucose
Conditions studied
- Diabetes, Gestational — all drugs for Diabetes, Gestational →
- Diabetes Mellitus Type 2 Pre-Existing — all drugs for Diabetes Mellitus Type 2 Pre-Existing →
Sponsor
University of Arkansas
Who can join
Adults 18 to 50, female only, with Diabetes, Gestational or Diabetes Mellitus Type 2 Pre-Existing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall objective is to test the feasibility and acceptability of a remote glucose monitoring program among Marshallese women with PGDM (pre-gestational diabetes mellitus) or GDM (gestational diabetes mellitus) and with limited English proficiency.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05453357
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes, Gestational
Currently open trials in the same condition.
- NCT05840497 — Effect of Strength-resistance Exercise in the Reduction of Gestational Diabetes in Pregnant Women with Overweight or Obe · NA · recruiting
- NCT04542148 — Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes · Phase 2 · active not recruiting
- NCT03607799 — A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes · NA · active not recruiting
- NCT04060056 — Westlake Precision Birth Cohort · NA · active not recruiting
- NCT03681054 — Dietary Management of Gestational Diabetes · NA · active not recruiting
Other University of Arkansas trials
Trials by the same sponsor.
- NCT07029776 — MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma · Phase 2 · not yet recruiting
- NCT07341399 — Essential Amino Acid Supplementation in Adult Spinal Deformity Patients · NA · not yet recruiting
- NCT07071766 — Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment · NA · recruiting
- NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
- NCT06604065 — Essential Amino Acids and Parkinsons Disease · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05453357 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Arkansas
- Last refreshed: 12 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05453357.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing